|
Volumn 10, Issue 4, 2000, Pages 467-481
|
The role of complement activation in hypersensitivity to pegylated liposomal Doxorubicin (Doxil®)
a a a a a a a |
Author keywords
Anaphylatoxins; Complement; Hemodynamics; Hypersensitivity reactions; Liposome
|
Indexed keywords
ANAPHYLATOXIN;
CAELIX;
CD11B ANTIGEN;
CD18 ANTIGEN;
COMPLEMENT;
COMPLEMENT COMPONENT C3B;
DOXORUBICIN;
CLINICAL FEATURE;
COMPLEMENT ACTIVATION;
CONFERENCE PAPER;
DRUG EFFECT;
DRUG FORMULATION;
DRUG HYPERSENSITIVITY;
DRUG INDUCED DISEASE;
DRUG RESPONSE;
HEART OUTPUT;
HUMAN;
HUMAN TISSUE;
HYPERSENSITIVITY REACTION;
HYPOTENSION;
IMMEDIATE TYPE HYPERSENSITIVITY;
IMMUNOPATHOGENESIS;
LYMPHOCYTE;
NORMAL HUMAN;
OPSONIZATION;
PATHOPHYSIOLOGY;
PHAGOCYTOSIS;
PRIORITY JOURNAL;
PULMONARY HYPERTENSION;
SERUM;
SWINE;
THEORY;
TREATMENT OUTCOME;
|
EID: 0034521835
PISSN: 08982104
EISSN: None
Source Type: Journal
DOI: 10.3109/08982100009031112 Document Type: Conference Paper |
Times cited : (84)
|
References (33)
|